Pharmaceutical Society reschedules Pharma Excellence Awards to April 11, 2025

0

The Pharmaceutical Society of Ghana (PSGH) has rescheduled the maiden PSGH Pharma Excellence Awards to April 11, 2025.

This has become necessary because of the large volume of entries received and thoroughly reviewed by the Pharma Excellence Awards Committee and the Panel of Reviewers.

Secondly, there’s a need for the various practice groups to vote on the practice groups’ pharmacist of the year – who will contribute a percentage of the marks to select the winner.

The awards will recognise and celebrate exceptional achievements of corporate bodies and individuals within the pharmaceutical industry and pharmaceutical care health sector.

The awards are also aimed at recognising the value of responsible professional, business and entrepreneurial practices that improve the standards of clinical practice, provision of healthcare and access to medical treatment or services; identify and recognise the talented organisations and individuals behind the work and create an environment where success is valued and commended.

The Pharma Excellence Awards’ maiden edition will convene industry leaders, quality professionals and stakeholders to celebrate excellence in a wide array of categories: including professional practice, manufacturing, research and development, distribution and marketing, quality control, quality assurance, regulatory affairs and compliance, corporate social responsibility, entrepreneurship, pharmaceutical care delivery and overall leadership.

Through these awards, exceptional individuals and teams will gain well-deserved recognition for their pivotal role in ensuring quality-assured products and patient-oriented pharmaceutical care services delivery, ultimately advancing national, regional and global public health.

In all, 26 awards will be given to deserving firms and individuals. They include OTC Brand of the Year; Pharmacy Only/POM Brand of the Year; Most Outstanding Export-oriented Pharma Manufacturer of the Year; and Pharma Multinational Company of the Year.